Fresh post-partum placentae were obtained from a local maternity hospital. After birth, the placenta was placed in a beaker containing cold saline and transported to the laboratory with the minimum of delay. Small pieces were taken randomly from the placenta and cut into 200-µ slices with a Mcllwain tissue chopper. The pooled slices were distributed among incubation flasks containing 20 ml Krebs' phosphate buffer, pH 7-4, to which had been added human serum albumin (250 µg/ml), glucose-6-phosphate (4 mM) and NADP (0-65 mM or 0-25 min). The medium also contained [7oc-3H]cholesterol (0-09 to 0-45 µ / ), previously purified by thin-layer chromatography and dissolved in propylene glycol (1 ml/100 ml incubation medium). The various test substances were added to the appropriate flasks. 142 J. R. Bedwani Incubations were carried out at 37°C in an atmosphere of oxygen, and terminated after 1 or 2 hr by rapid chilling followed by the addition of 0-5 ml N-NaOH. Known amounts of non-radioactive progesterone were added to enable measurements of recovery, and the contents of the flasks were homo¬ genized. Progesterone was isolated by solvent extraction (Bedwani & Marley, 1971 ) followed by chromatography on 0-7-g columns of silicic acid. The columns were eluted with 2 ml toluene followed by 16 ml 4% ethyl acetate in toluene. This fraction contained cholesterol and was discarded. Progesterone was then eluted with 4 ml 20% ethyl acetate in toluene and purified by two-dimensional thin-layer chromatography on silica gel G; the solvent systems were w-hexane: ethyl acetate, 5:2 and chloroform : acetone, 4:1.
Chromatograms were examined under ultraviolet light and the areas of silica gel containing the progesterone were eluted with 3 ml methanol. Radio¬ activity in 250-µ1 aliquots of the eluates was counted, using a liquid scintillation spectrometer, and the progesterone content was measured spectrophotometrically. The radiochemical purity of the [3H]progesterone extracted from placental incubates by this method was checked by adding 40 mg progesterone and recrystallizing from various solvents (Table 1 ) .
The conversion of cholesterol to progesterone by placental slices was in¬ creased greatly by the presence of NAD in the medium. The effects of different concentrations of the nucleotide, in the presence of a fixed concentration (4 mM) of glucose-6-phosphate, are shown in Text- fig. 1 . In each of two experi¬ ments, maximal stimulation was observed with a concentration of 0-25 mM.
An experiment was carried out to investigate the time course of the conversion of cholesterol to progesterone by placental slices incubated in the presence of NADP (0-65 mM). Incubations were carried out for up to 2 hr. After a delay of approximately 15 min, the formation of [3H]progesterone was found to in¬ crease linearly with time for the remainder of the experiment.
The effects of the various substances investigated on the conversion of [3H]cholesterol to [3H]progesterone are shown in Table 2 . Vasopressin, HCG, dibutyryl cyclic-AMP, PGF2cí, LTH, adrenaline and PGE1; in the concentrations used, had no effect on the formation of [3H]progesterone, but 5 mM-cyclic-AMP, in the presence of theophylline, reduced the conversion of cholesterol to progesterone (P<0-05). From the results of this investigation, it would appear that the synthesis of progesterone by the human placenta in vitro is not affected by gonadotrophic hormones or by prostaglandins found in the maternal blood and amniotic fluid.
Agents which have been shown to stimulate placental adenyl cyclase in vitro were also without effect on progesterone formation. The diminished production 3799 (3)* Incubations were carried out for 1 hr (Exps 3 to 5) or 2 hr (Exps 1 and 2). Values are corrected for losses during the extraction procedure, as measured by recovery of non-radioactive progesterone added at the end of incubation. of [3H]progesterone in the presence of cyclic-AMP was probably due to inhibi¬ tion of the conversion of pregnenolone to progesterone, as has been shown in the guinea-pig placenta (Bedwani & Marley, 1971 ) and other steroidogenic tissues (Koritz, Yun & Ferguson, 1968; Sulimovici & Boyd, 1969) . Plasma progesterone levels in early pregnancy can be elevated by infusions of vasopressin (Fylling, 1971) or by cervical dilatation, which is believed to stimulate the release of posterior pituitary hormones (Fylling & Norman, 1970) . The present results suggest that this effect of vasopressin is not due to direct stimulation of placental steroidogenesis. It should be noted, however, that the experiments reported here were carried out on placentae obtained after delivery, which may differ from pre-term placentae in their sensitivity to hormones. Another consideration is that the response of the placenta to hormones in vitro might differ from its response in vivo.
Both HCG and LH have been shown to stimulate the aromatization of testosterone to oestrogenic hormones by the human placenta perfused in vitro, an effect which is mimicked by cyclic-AMP (Cedard, Alsat, Urtasun & Varangot, 1970) . It is possible that the production of oestrogens by the placenta is controlled by gonadotrophic hormones, whilst the synthesis of progesterone is not regulated hormonally but by feedback control mediated by its biosynthetic intermediates and metabolic products (Wiener & Friedlander, 1971 ). I thank the National Institutes of Health, U.S.A., for a gift of LTH (NIH-P-S9), Dr J. E. Pike of the Upjohn Company, Kalamazoo, Michigan, for supplies of prostaglandins Et and F2st, and Boots Ltd for a sample of theophylline. Placentae were obtained through the staff of the Maternity Hospital, Mill Road, Cambridge, and I gratefully acknowledge their help.
